Hepatitis B infection (HBV) disease is one of the significant general wellbeing concerns. Around 2 billion contaminated people universally, 350 million incessant hepatitis and up to 1.2 million demise every year due to HBV disease have been made the crisis of this disease inescapable. Roughly 75% of patients with constant hepatitis live in Asia and Africa and up to 15-45% of HBV contaminated patients develops to cirrhosis, liver disappointment and hepatocellular carcinoma (HCC). Over 35% of Iranian populaces have been presented to HBV and over 3% of the network evaluated to be infection bearers. Since 1992, national inoculation program has been applied for neonates and ongoing examinations inferred a considerable decrease in the predominance of HBV disease from 2.5-7.2% in 1997 to 0.45% in 2003. Two enormous scaled investigation when national immunization program demonstrated a huge decrease in seropositivity rate in the age bunch 2-14 years (1.3% Vs. 0.8%, P<0.05). Besides the level of secured populace under inoculation has been improved from 62% in 1993 to 94% in 2005. Notwithstanding worthy reports of counteraction administrations, there is no effective treatment for the high level of solid bearers in the general public who have an impressive extent of included patients. These patients are in danger for ensuing cirrhosis and HCC and go about as a considerable hotspot for spreading the disease. Viability of Double Dose Intradermal Vaccination in Chronic Hepatitis B Carriers: A Double-Blinded Randomized Clinical Trial: Fariborz Mansour-Ghanaei, Farahnaz Joukar, Davood Khalili and Ali Kord Valeshabad.
Review Article: Hepatology and Pancreatic Science
Review Article: Hepatology and Pancreatic Science
Research Article: Hepatology and Pancreatic Science
Research Article: Hepatology and Pancreatic Science
Research Article: Hepatology and Pancreatic Science
Research Article: Hepatology and Pancreatic Science
Posters & Accepted Abstracts: Cancer Science & Therapy
Posters & Accepted Abstracts: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Keynote: Cancer Science & Therapy
Keynote: Pulmonary & Respiratory Medicine
Keynote: Pulmonary & Respiratory Medicine
Scientific Sessions&YRF: Cancer Science & Therapy
Scientific Sessions&YRF: Cancer Science & Therapy
Special Session: Cancer Science & Therapy
Special Session: Cancer Science & Therapy
Hepatology and Pancreatic Science received 34 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 